Myeloma, also known as multiple myeloma, is a rare and incurable cancer of the bone marrow. Around 12-15% of patients with myeloma may develop symptomatic AL amyloidosis, a related and rare disease that occurs when abnormal plasma cells in the bone marrow produce misfolded light chain proteins (“amyloid protein”).

In this section, you will find more information about myeloma and AL amyloidosis, the way they are diagnosed and how they are treated. Also, you will have additional information about clinical trials and psycho-social aspects of these diseases.